Skip to main content
. Author manuscript; available in PMC: 2014 Mar 5.
Published in final edited form as: Scand J Immunol. 2008 Oct 8;68(6):565–571. doi: 10.1111/j.1365-3083.2008.02176.x

Figure 5.

Figure 5

Therapeutic endogenous expression of human IL-10 in murine thymus increases survival in septic IL-10 knockout mice. IL-10−/− mice receiving the human IL-10 vector prior to CLP (▼) demonstrated a significant survival benefit compared to IL-10−/− mice pretreated with an empty vector (○) or buffer solution only (●). *P < 0.05 as determined by log-rank test in Kaplan–Meier survival analyses.